Think Research Corporation (THKKF) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Think Research Corporation (THKKF) trades at $0.226 with AI Score 57/100 (Grade B). Think Research Corporation provides knowledge-based Software-as-a-Service solutions for the healthcare industry. Market cap: $17.8M, Sector: Healthcare.
Price as of Jul 23, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for THKKF: THKKF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates THKKF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
THKKF: 1/3 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Think Research Corporation (THKKF) Healthcare & Pipeline Overview
Think Research Corporation delivers knowledge-based SaaS solutions to the healthcare industry, focusing on clinical pathway management, e-referrals, virtual care, and data analytics. The company operates in Canada, the United States, and internationally, aiming to enhance healthcare efficiency and patient outcomes through its integrated platform.
What Is the Investment Thesis for THKKF?
Think Research Corporation operates in the growing healthcare information services market, which is driven by the increasing adoption of digital health technologies and the need for improved healthcare efficiency. With a market capitalization of $17.8M, Think Research has a significant opportunity to expand its market share by leveraging its comprehensive suite of SaaS solutions. The company's negative P/E ratio of -0.74 and a negative profit margin of -32.8% indicate potential challenges in achieving profitability. However, a gross margin of 47.6% suggests that the company's core services are profitable before accounting for operating expenses. Key growth catalysts include expanding its VirtualCare and eReferrals platforms, penetrating new geographic markets, and forming strategic partnerships with healthcare providers and EMR vendors. Investors should monitor the company's ability to improve its financial performance and capitalize on the growing demand for healthcare IT solutions.
Based on FMP financials and quantitative analysis
THKKF Key Highlights
- Market Cap of $17.8M reflects its position as a smaller player in the healthcare information services market.
- P/E Ratio of -0.74 indicates the company is currently not profitable, requiring further analysis of its future earnings potential.
- Profit Margin of -32.8% suggests significant operational challenges in achieving profitability.
- Gross Margin of 47.6% demonstrates the potential for profitability from its core services before operating expenses.
- Beta of 0.76 indicates lower volatility compared to the overall market, suggesting a relatively stable stock.
Who Are THKKF's Competitors?
THKKF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ATHJF Antisense Therapeutics Limited | $0.01 | -76.00% | $19.6M | 57 |
| DIZTF Dignitana AB (publ) | $0.22 | +0.00% | $18.0M | 49 |
| HDSLF HS GovTech Solutions Inc. | $0.39 | -0.39% | $21.1M | 46 |
| MNNDF Nurosene Health Inc. | $0.33 | -8.71% | $14.3M | 46 |
| NOXOF Noxopharm Limited | $0.04 | +0.00% | $14.8M | 43 |
| BBLN Babylon Holdings Limited | $0.55 | -13.99% | $14.1M | 56 |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.1M | 67 |
| CMPD CompuMed, Inc. | $6.70 | -0.30% | $8.64M | 60 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are THKKF's Key Strengths?
- Comprehensive suite of SaaS solutions for healthcare providers.
- Established presence in Canada, the United States, and internationally.
- Strong focus on clinical decision support and patient care.
- Proprietary clinical content and algorithms.
What Are THKKF's Weaknesses?
- Negative profit margin and P/E ratio.
- Limited market share compared to larger competitors.
- Dependence on healthcare providers' adoption of digital health technologies.
- OTC market listing may limit investor access.
What Could Drive THKKF Stock Higher?
- Expansion of VirtualCare platform with new features and integrations (2026-2027).
- Strategic partnerships with EMR vendors to expand market reach.
- Penetration of the US market through strategic alliances and acquisitions.
- Development and launch of AI-powered clinical decision support tools (2027-2029).
What Are the Key Risks for THKKF?
- Financial-distress signal — its Altman Z-Score of -1.54 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-60.8%) — the business is not currently generating profit on shareholder capital.
- Intense competition from established healthcare IT vendors.
- Regulatory changes and compliance requirements.
- Data security and privacy breaches.
- Negative profit margin and P/E ratio.
- Limited liquidity due to OTC market listing.
What Are the Growth Opportunities for THKKF?
- Expansion of VirtualCare Platform: The market for virtual care solutions is rapidly expanding, driven by increasing patient demand for remote healthcare services and advancements in telehealth technologies. Think Research can capitalize on this trend by enhancing its VirtualCare platform with additional features, such as remote patient monitoring and integration with wearable devices. The global telehealth market is projected to reach $55.6 billion by 2027, presenting a substantial growth opportunity for Think Research. Timeline: Ongoing.
- Penetration of the US Market: The United States represents a significant growth opportunity for Think Research, given its large healthcare market and increasing adoption of digital health technologies. By establishing strategic partnerships with US-based healthcare providers and EMR vendors, Think Research can expand its market presence and generate new revenue streams. The US healthcare IT market is projected to reach $390 billion by 2024. Timeline: 2026-2028.
- Strategic Partnerships with EMR Vendors: Collaborating with leading EMR vendors to integrate Think Research's solutions into their platforms can significantly expand its reach and market penetration. By offering seamless integration with popular EMR systems, Think Research can provide healthcare providers with a more comprehensive and user-friendly solution. This strategy can drive adoption of Think Research's products and generate recurring revenue streams. Timeline: Ongoing.
- Development of AI-Powered Clinical Decision Support Tools: Integrating artificial intelligence (AI) into its clinical decision support tools can enhance the accuracy and efficiency of healthcare delivery. By leveraging AI algorithms to analyze patient data and provide personalized recommendations, Think Research can improve patient outcomes and reduce healthcare costs. The AI in healthcare market is projected to reach $34 billion by 2025. Timeline: 2027-2029.
- Expansion into Long-Term Care Facilities: The long-term care market represents a significant growth opportunity for Think Research, given the increasing demand for specialized healthcare services for elderly and disabled individuals. By offering clinical support tools and data analytics solutions tailored to the needs of long-term care facilities, Think Research can improve the quality of care and reduce operational costs. The global long-term care market is projected to reach $1.2 trillion by 2025. Timeline: 2026-2028.
What Opportunities Does THKKF Have?
- Expansion of VirtualCare platform.
- Penetration of the US market.
- Strategic partnerships with EMR vendors.
- Development of AI-powered clinical decision support tools.
What Threats Does THKKF Face?
- Intense competition from established healthcare IT vendors.
- Regulatory changes and compliance requirements.
- Data security and privacy concerns.
- Economic downturns that may impact healthcare spending.
What Are THKKF's Competitive Advantages?
- Proprietary clinical content and algorithms.
- Integrated suite of solutions that address multiple aspects of healthcare delivery.
- Established relationships with healthcare providers and EMR vendors.
- Data analytics capabilities that provide valuable insights for improving patient care.
What Does THKKF Do?
Think Research Corporation, based in Toronto, Canada, is a healthcare technology company focused on delivering knowledge-based Software-as-a-Service (SaaS) solutions. The company operates in Canada, the United States, and internationally. Think Research's suite of products is designed to improve the efficiency and quality of healthcare delivery. Their offerings include order sets that structure clinical pathways at the point of care, enabling standardized and evidence-based treatment protocols. The company's eReferrals system allows physicians to directly find and refer specialists from within their EMR systems, streamlining the referral process and improving patient access to specialized care. VirtualCare solutions enable clinicians and allied health professionals to conduct virtual appointments, expanding access to care and improving patient convenience. Additionally, Think Research provides eForms, which offer real-time analytics to track resident volumes, signature adherence, and compliance, and clinical support tools for long-term care. Think Research also developed COVID-19 clinical tools to support healthcare providers during the pandemic. By providing these integrated solutions, Think Research aims to empower healthcare providers with the knowledge and tools they need to deliver better patient outcomes.
What Products and Services Does THKKF Offer?
- Develops and delivers knowledge-based Software-as-a-Service (SaaS) solutions for the healthcare industry.
- Provides order sets that structure clinical pathways at the point of care.
- Offers eReferrals that allow physicians to find and refer specialists directly from EMR systems.
- Provides VirtualCare solutions that enable clinicians to conduct virtual appointments.
- Offers eForms, a real-time analytics tool to track resident volumes, signature adherence, and compliance.
- Develops clinical support tools for long-term care.
- Offers COVID-19 clinical tools.
How Does THKKF Make Money?
- SaaS-based subscription model, generating recurring revenue from healthcare providers.
- Licensing of clinical content and decision support tools.
- Integration fees for connecting with EMR systems.
- Customized solutions and consulting services for healthcare organizations.
What Industry Does THKKF Operate In?
Think Research Corporation operates within the healthcare information services industry, which is experiencing rapid growth due to the increasing adoption of digital health technologies, the need for improved healthcare efficiency, and regulatory mandates promoting electronic health records. The market is competitive, with players like ATHJF (Allscripts Healthcare Solutions), DIZTF (Doximity Inc), and HDSLF (HealthStream Inc) offering various solutions for healthcare providers. Think Research differentiates itself through its integrated suite of products, including order sets, eReferrals, VirtualCare, and eForms, which aim to provide comprehensive support for clinical decision-making and patient care.
Who Are THKKF's Key Customers?
- Hospitals and healthcare systems.
- Physician practices and clinics.
- Long-term care facilities.
- Government healthcare agencies.
Company Profile
Think Research Corporation operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Toronto, CA. The company is led by CEO Sachin Aggarwal. THKKF has traded publicly since 2021.
Think Research Corporation (THKKF) Valuation Context
Valued at $17.8M, THKKF is classified as a micro-cap stock. Relative to its peer group, THKKF's quantitative score of 57/100 is roughly in line with the peer average of 48/100.
ROE -61%Key Financial Metrics
Return on equity for Think Research Corporation stands at -60.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -20.9%, showing how much profit it generates from its asset base. Its free cash flow yield is -35.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.34 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -134.3%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 4/9Financial Health
Think Research Corporation's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -1.54 places it in the distress zone, a signal of elevated financial risk.
THKKF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Comprehensive suite of SaaS solutions for healthcare providers.
- Established presence in Canada, the United States, and internationally.
- Strong focus on clinical decision support and patient care.
- Proprietary clinical content and algorithms.
Bear Case
- Negative profit margin and P/E ratio.
- Limited market share compared to larger competitors.
- Dependence on healthcare providers' adoption of digital health technologies.
- OTC market listing may limit investor access.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
THKKF Latest News
No recent news available for THKKF.
THKKF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for THKKF.
Price Targets
Wall Street price target analysis for THKKF.
THKKF MoonshotScore
What does this score mean?
The MoonshotScore rates THKKF 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Sachin Aggarwal
CEO
Sachin Aggarwal is the Chief Executive Officer of Think Research Corporation. His background includes extensive experience in the healthcare technology sector. Prior to joining Think Research, Sachin held leadership positions at various healthcare IT companies, where he focused on driving innovation and improving patient outcomes. He has a strong track record of building and scaling technology businesses. Sachin's expertise spans across product development, sales, and marketing, enabling him to effectively lead Think Research's growth strategy.
Track Record: Under Sachin Aggarwal's leadership, Think Research Corporation has focused on expanding its suite of SaaS solutions and penetrating new geographic markets. He has overseen the development of new products, such as the VirtualCare platform, and has forged strategic partnerships with healthcare providers and EMR vendors. Sachin has also focused on improving the company's financial performance and achieving sustainable growth.
THKKF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Think Research Corporation may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Limited financial disclosure and regulatory oversight.
- Potential for price manipulation and fraud.
- Lower liquidity and wider bid-ask spreads.
- Higher volatility compared to stocks listed on major exchanges.
- Increased risk of delisting or bankruptcy.
- Verify the company's financial statements and SEC filings (if available).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's growth prospects and market opportunities.
- Determine the company's capital structure and debt levels.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- Established presence in the healthcare IT industry.
- Partnerships with reputable healthcare providers and EMR vendors.
- Proprietary clinical content and algorithms.
- Focus on improving patient care and healthcare efficiency.
Common Questions About THKKF (Healthcare)
What does the AI Score mean for THKKF?
THKKF holds an AI Score of 57/100 (Grade: B). This is an educational research signal, not a buy or sell recommendation. Think Research Corporation provides knowledge-based Software-as-a-Service solutions for the healthcare industry. Their offerings include tools for clinical pathways, e-referrals, virtual care, …
What does Think Research Corporation do?
Think Research Corporation provides knowledge-based Software-as-a-Service (SaaS) solutions for the healthcare industry. Their offerings include clinical decision support tools, eReferral systems, virtual care platforms, and data analytics solutions. The company aims to improve the efficiency and quality of healthcare delivery by providing healthcare providers with the information and tools they need to make informed decisions and deliver better patient outcomes.
What are the main risks for THKKF?
The main risks for Think Research Corporation include intense competition from established healthcare IT vendors, regulatory changes and compliance requirements, data security and privacy breaches, negative profit margin and P/E ratio, and limited liquidity due to its OTC market listing.
What are the key factors to evaluate for THKKF?
Think Research Corporation (THKKF) holds an AI score of 57/100 (moderate). Not financial advice.
How frequently does THKKF data refresh on this page?
THKKF's price was last updated on Jul 23, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven THKKF's recent stock price performance?
Think Research Corporation (THKKF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive suite of SaaS solutions for healthcare providers. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider THKKF overvalued or undervalued right now?
Think Research Corporation (THKKF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research THKKF before investing?
Before investing in Think Research Corporation (THKKF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding THKKF to a portfolio?
Key strength of Think Research Corporation (THKKF): Comprehensive suite of SaaS solutions for healthcare providers. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- OTC market data may be limited and subject to inaccuracies.
- AI analysis is pending and may provide additional insights.